Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Aug;83(16):8254-8.
doi: 10.1128/JVI.00580-09. Epub 2009 Jun 3.

Suppression of human immunodeficiency virus type 1 (HIV-1) viremia with reverse transcriptase and integrase inhibitors, CD4+ T-cell recovery, and viral rebound upon interruption of therapy in a new model for HIV treatment in the humanized Rag2-/-{gamma}c-/- mouse

Affiliations

Suppression of human immunodeficiency virus type 1 (HIV-1) viremia with reverse transcriptase and integrase inhibitors, CD4+ T-cell recovery, and viral rebound upon interruption of therapy in a new model for HIV treatment in the humanized Rag2-/-{gamma}c-/- mouse

Shailesh K Choudhary et al. J Virol. 2009 Aug.

Abstract

A small animal model that reproduces human immunodeficiency virus type 1 (HIV-1) pathogenesis may allow modeling of new therapeutic strategies in ways not approachable in mononuclear cell culture. We find that, as in humans, combination antiretroviral therapy (ART) in humanized (hu-) Rag2(-/-)gamma(c)(-/-) mice allows suppression of viremia below the limits of detection and recovery of CD4(+) cells, while interruption of ART results in viral rebound and renewed loss of CD4(+) T cells. Failure of ART in infected mice is associated with the appearance of drug resistance mutations. The hu-Rag2(-/-)gamma(c)(-/-) mouse may therefore facilitate testing of novel approaches to HIV replication and persistence.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Pharmacokinetics of ART in Rag2−/−γc−/− mice. Mice were dosed with FTC, TFV, and L-870812 (L-812) at 60, 50 and 20 mg/kg body weight by single intraperitoneal injection. Serum and gastrointestinal tissue samples from ileum and rectum were collected and frozen at −80°C until analysis. As the PK profiles were similar for ileum and rectal regions of IT, data were combined. The data shown are the mean concentration ± standard error of the single-dose PK profile of FTC, TFV, and L-870812 over a 24-h period in serum (A) and IT (B) of mice after combined intraperitoneal injection. n = 3 for serum, and n = 6 for tissue.
FIG. 2.
FIG. 2.
hu-CD4+ T-cell reconstitution, infection, and novel antiretroviral therapy in hu-Rag2−/−γc−/− mice. (A) T-cell reconstitution at 20 weeks postengraftment. Live cells were defined based on their forward and side scatter and single cells based on forward scatter height and area. Single, live cells were subsequently gated on the hu-CD45+/mouse CD45 and hu-CD3+ population. (B) Memory hu-CD4+ T cells reconstitute in blood and tissue. Human T cells gated on the CD4+ population (circled) were analyzed for memory marker CD45RO and activation marker CD25. PBMC, peripheral blood mononuclear cells. (C) hu-CD4+ T-cell expression of CCR5 and CXCR4. (D) hu-CD11b+ cells are detected in several lymphoid tissues. (E) Suppression of plasma viremia and recovery of hu-CD4+ T cells in individual hu-Rag2−/−γc−/− mice. Animals were infected with JRCSF (25 ng p24/mouse) and treated with L-870812, TFV, and FTC at 20, 50, and 60 mg/kg/daily, respectively. Blue lines and squares show plasma viremia, while green lines and triangles show CD4+ percentages, both drawn on a logarithmic scale. The percentage of hu-CD4+ T cells represents the percentage of this cell population in total peripheral blood mononuclear cells obtained from mouse blood. The percentage of hu-CD4+ T cells = % hu-CD45+/mouse CD45 cells × (% CD3+ cells gated on hu-CD45+ cells/100) × (% CD4+ cells gated on hu-CD45+ CD3+/100). Due to the small available volume of mouse plasma, dilution is required, and so the limit of assay detection of viral RNA is <500 copies (Cps)/ml. Shading indicates time prior to infection (green), following infection (purple), after initiation of ART (yellow), and following discontinuation of ART (gray). TFV- and L-870812-related mutations were detected in plasma of M4 and M5 upon failure of therapy or rebound. Experiments terminated by death of the mouse are indicated by asterisks.

Similar articles

Cited by

References

    1. Ambrose, Z., V. Boltz, S. Palmer, J. M. Coffin, S. H. Hughes, and V. N. KewalRamani. 2004. In vitro characterization of a simian immunodeficiency virus-human immunodeficiency virus (HIV) chimera expressing HIV type 1 reverse transcriptase to study antiviral resistance in pigtail macaques. J. Virol. 7813553-13561. - PMC - PubMed
    1. Ambrose, Z., S. Palmer, V. F. Boltz, M. Kearney, K. Larsen, P. Polacino, L. Flanary, K. Oswald, M. Piatak, Jr., J. Smedley, W. Shao, N. Bischofberger, F. Maldarelli, J. T. Kimata, J. W. Mellors, S. L. Hu, J. M. Coffin, J. D. Lifson, and V. N. KewalRamani. 2007. Suppression of viremia and evolution of human immunodeficiency virus type 1 drug resistance in a macaque model for antiretroviral therapy. J. Virol. 8112145-12155. - PMC - PubMed
    1. Baenziger, S., R. Tussiwand, E. Schlaepfer, L. Mazzucchelli, M. Heikenwalder, M. O. Kurrer, S. Behnke, J. Frey, A Oxenius, H Joller, A Aguzzi, M. G. Manz, and R. F. Speck. 2006. Disseminated and sustained HIV infection in CD34+ cord blood cell-transplanted Rag2−/−γc−/− mice. Proc. Natl. Acad. Sci. USA 10315951-15956. - PMC - PubMed
    1. Berges, B. K., S. R. Akkina, J. M. Folkvord, E. Connick, and R. Akkina. 2008. Mucosal transmission of R5 and X4 tropic HIV-1 via vaginal and rectal routes in humanized Rag2−/− γc−/− (RAG-hu) mice. Virology 373342-351. - PMC - PubMed
    1. Berges, B. K., W. H. Wheat, B. E. Palmer, E. Connick, and R. Akkina. 2006. HIV-1 infection and CD4 T cell depletion in the humanized Rag2−/− γc−/− (RAG-hu) mouse model. Retrovirology 376. - PMC - PubMed

Publication types

MeSH terms